Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Linagliptin + Metformin & Type 2 Diabetes (T2D), the FDA approved Linagliptin + Metformin on January 30, 2012 for improving glycemic control in adults with type 2 diabetes (T2D) as an adjunct to diet and exercise.
FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adult patients with type 2 diabetes
The [European Medicines Agency (EMA…